nodes	percent_of_prediction	percent_of_DWPC	metapath
Glipizide—CYP3A4—Everolimus—kidney cancer	0.11	0.208	CbGbCtD
Glipizide—CYP3A4—Temsirolimus—kidney cancer	0.0745	0.141	CbGbCtD
Glipizide—CYP2C9—Capecitabine—kidney cancer	0.0702	0.132	CbGbCtD
Glipizide—CYP2C9—Paclitaxel—kidney cancer	0.044	0.0829	CbGbCtD
Glipizide—CYP3A4—Pazopanib—kidney cancer	0.0391	0.0738	CbGbCtD
Glipizide—CYP2C9—Sorafenib—kidney cancer	0.0391	0.0737	CbGbCtD
Glipizide—CYP3A4—Erlotinib—kidney cancer	0.0279	0.0527	CbGbCtD
Glipizide—CYP3A4—Paclitaxel—kidney cancer	0.0256	0.0482	CbGbCtD
Glipizide—CYP3A4—Sorafenib—kidney cancer	0.0227	0.0428	CbGbCtD
Glipizide—CYP3A4—Vinblastine—kidney cancer	0.0224	0.0423	CbGbCtD
Glipizide—CYP3A4—Vincristine—kidney cancer	0.022	0.0416	CbGbCtD
Glipizide—CYP3A4—Sunitinib—kidney cancer	0.0184	0.0347	CbGbCtD
Glipizide—CYP3A4—Doxorubicin—kidney cancer	0.0138	0.026	CbGbCtD
Glipizide—PPARG—nephron—kidney cancer	0.00791	0.346	CbGeAlD
Glipizide—PPARG—Everolimus—Temsirolimus—kidney cancer	0.00641	1	CbGdCrCtD
Glipizide—CYP2C9—urine—kidney cancer	0.00371	0.162	CbGeAlD
Glipizide—CYP3A4—urine—kidney cancer	0.00283	0.124	CbGeAlD
Glipizide—Gliclazide—VEGFA—kidney cancer	0.0027	0.573	CrCbGaD
Glipizide—ABCC8—renal system—kidney cancer	0.00203	0.0889	CbGeAlD
Glipizide—ABCC8—kidney—kidney cancer	0.00197	0.086	CbGeAlD
Glipizide—PPARG—renal system—kidney cancer	0.00155	0.0679	CbGeAlD
Glipizide—PPARG—kidney—kidney cancer	0.0015	0.0656	CbGeAlD
Glipizide—Chlorpropamide—PTGS1—kidney cancer	0.00111	0.235	CrCbGaD
Glipizide—CYP3A4—renal system—kidney cancer	0.000693	0.0303	CbGeAlD
Glipizide—CYP3A4—kidney—kidney cancer	0.00067	0.0293	CbGeAlD
Glipizide—Chlorpropamide—ABCB1—kidney cancer	0.000539	0.114	CrCbGaD
Glipizide—Thrombocytopenia—Gemcitabine—kidney cancer	0.000385	0.00108	CcSEcCtD
Glipizide—Feeling abnormal—Dactinomycin—kidney cancer	0.000382	0.00107	CcSEcCtD
Glipizide—Rhinitis—Capecitabine—kidney cancer	0.000381	0.00107	CcSEcCtD
Glipizide—Hepatitis—Capecitabine—kidney cancer	0.00038	0.00107	CcSEcCtD
Glipizide—Vision blurred—Paclitaxel—kidney cancer	0.00038	0.00107	CcSEcCtD
Glipizide—Hyperhidrosis—Gemcitabine—kidney cancer	0.00038	0.00107	CcSEcCtD
Glipizide—Gastrointestinal pain—Dactinomycin—kidney cancer	0.000379	0.00107	CcSEcCtD
Glipizide—Hypoaesthesia—Capecitabine—kidney cancer	0.000378	0.00106	CcSEcCtD
Glipizide—Tremor—Paclitaxel—kidney cancer	0.000378	0.00106	CcSEcCtD
Glipizide—Musculoskeletal discomfort—Vincristine—kidney cancer	0.000378	0.00106	CcSEcCtD
Glipizide—Pharyngitis—Capecitabine—kidney cancer	0.000377	0.00106	CcSEcCtD
Glipizide—Hypersensitivity—Sorafenib—kidney cancer	0.000375	0.00105	CcSEcCtD
Glipizide—Insomnia—Vincristine—kidney cancer	0.000375	0.00105	CcSEcCtD
Glipizide—Anorexia—Gemcitabine—kidney cancer	0.000375	0.00105	CcSEcCtD
Glipizide—Vomiting—Vinblastine—kidney cancer	0.000374	0.00105	CcSEcCtD
Glipizide—Dizziness—Erlotinib—kidney cancer	0.000374	0.00105	CcSEcCtD
Glipizide—Ill-defined disorder—Paclitaxel—kidney cancer	0.000374	0.00105	CcSEcCtD
Glipizide—Vomiting—Everolimus—kidney cancer	0.000373	0.00105	CcSEcCtD
Glipizide—Paraesthesia—Vincristine—kidney cancer	0.000372	0.00104	CcSEcCtD
Glipizide—Rash—Everolimus—kidney cancer	0.00037	0.00104	CcSEcCtD
Glipizide—Dermatitis—Everolimus—kidney cancer	0.00037	0.00104	CcSEcCtD
Glipizide—Headache—Vinblastine—kidney cancer	0.000369	0.00104	CcSEcCtD
Glipizide—Headache—Everolimus—kidney cancer	0.000368	0.00103	CcSEcCtD
Glipizide—Abdominal pain—Dactinomycin—kidney cancer	0.000367	0.00103	CcSEcCtD
Glipizide—Visual impairment—Capecitabine—kidney cancer	0.000366	0.00103	CcSEcCtD
Glipizide—Asthenia—Sorafenib—kidney cancer	0.000365	0.00103	CcSEcCtD
Glipizide—Glyburide—ABCB1—kidney cancer	0.000364	0.0772	CrCbGaD
Glipizide—Malaise—Paclitaxel—kidney cancer	0.000364	0.00102	CcSEcCtD
Glipizide—Hypoglycaemia—Doxorubicin—kidney cancer	0.000363	0.00102	CcSEcCtD
Glipizide—Vertigo—Paclitaxel—kidney cancer	0.000362	0.00102	CcSEcCtD
Glipizide—Syncope—Paclitaxel—kidney cancer	0.000362	0.00102	CcSEcCtD
Glipizide—Leukopenia—Paclitaxel—kidney cancer	0.000361	0.00101	CcSEcCtD
Glipizide—Hypersensitivity—Sunitinib—kidney cancer	0.000361	0.00101	CcSEcCtD
Glipizide—Decreased appetite—Vincristine—kidney cancer	0.00036	0.00101	CcSEcCtD
Glipizide—Pruritus—Sorafenib—kidney cancer	0.00036	0.00101	CcSEcCtD
Glipizide—Vomiting—Erlotinib—kidney cancer	0.00036	0.00101	CcSEcCtD
Glipizide—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.000358	0.00101	CcSEcCtD
Glipizide—Gastrointestinal disorder—Vincristine—kidney cancer	0.000358	0.001	CcSEcCtD
Glipizide—Rash—Erlotinib—kidney cancer	0.000357	0.001	CcSEcCtD
Glipizide—Dermatitis—Erlotinib—kidney cancer	0.000357	0.001	CcSEcCtD
Glipizide—Hyponatraemia—Doxorubicin—kidney cancer	0.000356	0.000999	CcSEcCtD
Glipizide—Insomnia—Gemcitabine—kidney cancer	0.000356	0.000998	CcSEcCtD
Glipizide—Eye disorder—Capecitabine—kidney cancer	0.000355	0.000998	CcSEcCtD
Glipizide—Headache—Erlotinib—kidney cancer	0.000355	0.000996	CcSEcCtD
Glipizide—Loss of consciousness—Paclitaxel—kidney cancer	0.000355	0.000995	CcSEcCtD
Glipizide—Pain—Vincristine—kidney cancer	0.000354	0.000995	CcSEcCtD
Glipizide—Constipation—Vincristine—kidney cancer	0.000354	0.000995	CcSEcCtD
Glipizide—Diplopia—Doxorubicin—kidney cancer	0.000354	0.000995	CcSEcCtD
Glipizide—Gastrointestinal haemorrhage—Doxorubicin—kidney cancer	0.000354	0.000995	CcSEcCtD
Glipizide—Paraesthesia—Gemcitabine—kidney cancer	0.000353	0.000991	CcSEcCtD
Glipizide—Flushing—Capecitabine—kidney cancer	0.000353	0.000991	CcSEcCtD
Glipizide—Asthenia—Sunitinib—kidney cancer	0.000352	0.000987	CcSEcCtD
Glipizide—Dyspnoea—Gemcitabine—kidney cancer	0.000351	0.000984	CcSEcCtD
Glipizide—Nausea—Vinblastine—kidney cancer	0.00035	0.000982	CcSEcCtD
Glipizide—Somnolence—Gemcitabine—kidney cancer	0.00035	0.000981	CcSEcCtD
Glipizide—Migraine—Doxorubicin—kidney cancer	0.000349	0.000979	CcSEcCtD
Glipizide—Nausea—Everolimus—kidney cancer	0.000348	0.000978	CcSEcCtD
Glipizide—Diarrhoea—Sorafenib—kidney cancer	0.000348	0.000978	CcSEcCtD
Glipizide—Hypertension—Paclitaxel—kidney cancer	0.000348	0.000978	CcSEcCtD
Glipizide—Pruritus—Sunitinib—kidney cancer	0.000347	0.000973	CcSEcCtD
Glipizide—Myalgia—Paclitaxel—kidney cancer	0.000343	0.000964	CcSEcCtD
Glipizide—Arthralgia—Paclitaxel—kidney cancer	0.000343	0.000964	CcSEcCtD
Glipizide—Anxiety—Paclitaxel—kidney cancer	0.000342	0.000961	CcSEcCtD
Glipizide—Decreased appetite—Gemcitabine—kidney cancer	0.000342	0.00096	CcSEcCtD
Glipizide—Hypersensitivity—Dactinomycin—kidney cancer	0.000342	0.00096	CcSEcCtD
Glipizide—Chills—Capecitabine—kidney cancer	0.000341	0.000958	CcSEcCtD
Glipizide—Arrhythmia—Capecitabine—kidney cancer	0.00034	0.000954	CcSEcCtD
Glipizide—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000339	0.000953	CcSEcCtD
Glipizide—Discomfort—Paclitaxel—kidney cancer	0.000339	0.000953	CcSEcCtD
Glipizide—Gastrointestinal pain—Vincristine—kidney cancer	0.000339	0.000952	CcSEcCtD
Glipizide—Dizziness—Sorafenib—kidney cancer	0.000337	0.000945	CcSEcCtD
Glipizide—Pain—Gemcitabine—kidney cancer	0.000336	0.000944	CcSEcCtD
Glipizide—Constipation—Gemcitabine—kidney cancer	0.000336	0.000944	CcSEcCtD
Glipizide—Nausea—Erlotinib—kidney cancer	0.000336	0.000944	CcSEcCtD
Glipizide—Diarrhoea—Sunitinib—kidney cancer	0.000335	0.000941	CcSEcCtD
Glipizide—Asthenia—Dactinomycin—kidney cancer	0.000333	0.000934	CcSEcCtD
Glipizide—Confusional state—Paclitaxel—kidney cancer	0.000332	0.000932	CcSEcCtD
Glipizide—Erythema—Capecitabine—kidney cancer	0.000331	0.000929	CcSEcCtD
Glipizide—Oedema—Paclitaxel—kidney cancer	0.000329	0.000924	CcSEcCtD
Glipizide—Abdominal pain—Vincristine—kidney cancer	0.000328	0.00092	CcSEcCtD
Glipizide—Flatulence—Capecitabine—kidney cancer	0.000326	0.000916	CcSEcCtD
Glipizide—Dizziness—Sunitinib—kidney cancer	0.000324	0.00091	CcSEcCtD
Glipizide—Feeling abnormal—Gemcitabine—kidney cancer	0.000324	0.00091	CcSEcCtD
Glipizide—Shock—Paclitaxel—kidney cancer	0.000324	0.000909	CcSEcCtD
Glipizide—Vomiting—Sorafenib—kidney cancer	0.000324	0.000909	CcSEcCtD
Glipizide—Abdominal pain upper—Doxorubicin—kidney cancer	0.000324	0.000909	CcSEcCtD
Glipizide—Thrombocytopenia—Paclitaxel—kidney cancer	0.000322	0.000905	CcSEcCtD
Glipizide—Rash—Sorafenib—kidney cancer	0.000321	0.000901	CcSEcCtD
Glipizide—Dermatitis—Sorafenib—kidney cancer	0.000321	0.000901	CcSEcCtD
Glipizide—Headache—Sorafenib—kidney cancer	0.000319	0.000896	CcSEcCtD
Glipizide—Muscle spasms—Capecitabine—kidney cancer	0.000318	0.000893	CcSEcCtD
Glipizide—Hyperhidrosis—Paclitaxel—kidney cancer	0.000318	0.000893	CcSEcCtD
Glipizide—Diarrhoea—Dactinomycin—kidney cancer	0.000317	0.000891	CcSEcCtD
Glipizide—Anorexia—Paclitaxel—kidney cancer	0.000314	0.000881	CcSEcCtD
Glipizide—Vision blurred—Capecitabine—kidney cancer	0.000312	0.000876	CcSEcCtD
Glipizide—Vomiting—Sunitinib—kidney cancer	0.000312	0.000875	CcSEcCtD
Glipizide—Tremor—Capecitabine—kidney cancer	0.00031	0.000871	CcSEcCtD
Glipizide—Rash—Sunitinib—kidney cancer	0.000309	0.000867	CcSEcCtD
Glipizide—Dermatitis—Sunitinib—kidney cancer	0.000309	0.000867	CcSEcCtD
Glipizide—Ill-defined disorder—Capecitabine—kidney cancer	0.000307	0.000862	CcSEcCtD
Glipizide—Headache—Sunitinib—kidney cancer	0.000307	0.000862	CcSEcCtD
Glipizide—Hypersensitivity—Vincristine—kidney cancer	0.000305	0.000857	CcSEcCtD
Glipizide—Nausea—Sorafenib—kidney cancer	0.000302	0.000849	CcSEcCtD
Glipizide—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.0003	0.000842	CcSEcCtD
Glipizide—Malaise—Capecitabine—kidney cancer	0.000299	0.000838	CcSEcCtD
Glipizide—Insomnia—Paclitaxel—kidney cancer	0.000298	0.000836	CcSEcCtD
Glipizide—Vertigo—Capecitabine—kidney cancer	0.000297	0.000835	CcSEcCtD
Glipizide—Asthenia—Vincristine—kidney cancer	0.000297	0.000835	CcSEcCtD
Glipizide—Syncope—Capecitabine—kidney cancer	0.000297	0.000833	CcSEcCtD
Glipizide—Leukopenia—Capecitabine—kidney cancer	0.000296	0.000832	CcSEcCtD
Glipizide—Paraesthesia—Paclitaxel—kidney cancer	0.000296	0.00083	CcSEcCtD
Glipizide—Vomiting—Dactinomycin—kidney cancer	0.000295	0.000828	CcSEcCtD
Glipizide—Dyspnoea—Paclitaxel—kidney cancer	0.000293	0.000824	CcSEcCtD
Glipizide—Somnolence—Paclitaxel—kidney cancer	0.000293	0.000822	CcSEcCtD
Glipizide—Rash—Dactinomycin—kidney cancer	0.000292	0.000821	CcSEcCtD
Glipizide—Nausea—Sunitinib—kidney cancer	0.000291	0.000817	CcSEcCtD
Glipizide—Loss of consciousness—Capecitabine—kidney cancer	0.000291	0.000817	CcSEcCtD
Glipizide—Pancytopenia—Doxorubicin—kidney cancer	0.000291	0.000816	CcSEcCtD
Glipizide—Dyspepsia—Paclitaxel—kidney cancer	0.00029	0.000814	CcSEcCtD
Glipizide—Dysuria—Doxorubicin—kidney cancer	0.000286	0.000804	CcSEcCtD
Glipizide—Decreased appetite—Paclitaxel—kidney cancer	0.000286	0.000803	CcSEcCtD
Glipizide—Hypertension—Capecitabine—kidney cancer	0.000286	0.000802	CcSEcCtD
Glipizide—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000284	0.000798	CcSEcCtD
Glipizide—Diarrhoea—Vincristine—kidney cancer	0.000284	0.000796	CcSEcCtD
Glipizide—Asthenia—Gemcitabine—kidney cancer	0.000282	0.000792	CcSEcCtD
Glipizide—Arthralgia—Capecitabine—kidney cancer	0.000282	0.000791	CcSEcCtD
Glipizide—Myalgia—Capecitabine—kidney cancer	0.000282	0.000791	CcSEcCtD
Glipizide—Pain—Paclitaxel—kidney cancer	0.000282	0.00079	CcSEcCtD
Glipizide—Constipation—Paclitaxel—kidney cancer	0.000282	0.00079	CcSEcCtD
Glipizide—Anxiety—Capecitabine—kidney cancer	0.000281	0.000788	CcSEcCtD
Glipizide—Photosensitivity reaction—Doxorubicin—kidney cancer	0.00028	0.000785	CcSEcCtD
Glipizide—Discomfort—Capecitabine—kidney cancer	0.000278	0.000782	CcSEcCtD
Glipizide—Pruritus—Gemcitabine—kidney cancer	0.000278	0.000781	CcSEcCtD
Glipizide—Nausea—Dactinomycin—kidney cancer	0.000276	0.000774	CcSEcCtD
Glipizide—Dizziness—Vincristine—kidney cancer	0.000274	0.00077	CcSEcCtD
Glipizide—Drowsiness—Doxorubicin—kidney cancer	0.000273	0.000767	CcSEcCtD
Glipizide—Confusional state—Capecitabine—kidney cancer	0.000272	0.000765	CcSEcCtD
Glipizide—Feeling abnormal—Paclitaxel—kidney cancer	0.000271	0.000762	CcSEcCtD
Glipizide—Oedema—Capecitabine—kidney cancer	0.00027	0.000758	CcSEcCtD
Glipizide—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000269	0.000756	CcSEcCtD
Glipizide—Diarrhoea—Gemcitabine—kidney cancer	0.000269	0.000755	CcSEcCtD
Glipizide—Jaundice—Doxorubicin—kidney cancer	0.000266	0.000747	CcSEcCtD
Glipizide—Shock—Capecitabine—kidney cancer	0.000266	0.000746	CcSEcCtD
Glipizide—Conjunctivitis—Doxorubicin—kidney cancer	0.000265	0.000745	CcSEcCtD
Glipizide—Thrombocytopenia—Capecitabine—kidney cancer	0.000265	0.000743	CcSEcCtD
Glipizide—Vomiting—Vincristine—kidney cancer	0.000264	0.00074	CcSEcCtD
Glipizide—Sweating—Doxorubicin—kidney cancer	0.000262	0.000735	CcSEcCtD
Glipizide—Urticaria—Paclitaxel—kidney cancer	0.000262	0.000734	CcSEcCtD
Glipizide—Rash—Vincristine—kidney cancer	0.000261	0.000734	CcSEcCtD
Glipizide—Hyperhidrosis—Capecitabine—kidney cancer	0.000261	0.000733	CcSEcCtD
Glipizide—Dermatitis—Vincristine—kidney cancer	0.000261	0.000733	CcSEcCtD
Glipizide—Abdominal pain—Paclitaxel—kidney cancer	0.00026	0.000731	CcSEcCtD
Glipizide—Headache—Vincristine—kidney cancer	0.00026	0.000729	CcSEcCtD
Glipizide—Hepatobiliary disease—Doxorubicin—kidney cancer	0.000258	0.000725	CcSEcCtD
Glipizide—Anorexia—Capecitabine—kidney cancer	0.000258	0.000723	CcSEcCtD
Glipizide—Agranulocytosis—Doxorubicin—kidney cancer	0.000255	0.000715	CcSEcCtD
Glipizide—Vomiting—Gemcitabine—kidney cancer	0.00025	0.000702	CcSEcCtD
Glipizide—Rash—Gemcitabine—kidney cancer	0.000248	0.000696	CcSEcCtD
Glipizide—Dermatitis—Gemcitabine—kidney cancer	0.000248	0.000695	CcSEcCtD
Glipizide—Headache—Gemcitabine—kidney cancer	0.000246	0.000692	CcSEcCtD
Glipizide—Nausea—Vincristine—kidney cancer	0.000246	0.000691	CcSEcCtD
Glipizide—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.000246	0.000691	CcSEcCtD
Glipizide—Rhinitis—Doxorubicin—kidney cancer	0.000246	0.00069	CcSEcCtD
Glipizide—Hepatitis—Doxorubicin—kidney cancer	0.000245	0.000688	CcSEcCtD
Glipizide—Insomnia—Capecitabine—kidney cancer	0.000244	0.000686	CcSEcCtD
Glipizide—Hypoaesthesia—Doxorubicin—kidney cancer	0.000244	0.000685	CcSEcCtD
Glipizide—Pharyngitis—Doxorubicin—kidney cancer	0.000243	0.000683	CcSEcCtD
Glipizide—Paraesthesia—Capecitabine—kidney cancer	0.000243	0.000681	CcSEcCtD
Glipizide—Hypersensitivity—Paclitaxel—kidney cancer	0.000243	0.000681	CcSEcCtD
Glipizide—Dyspnoea—Capecitabine—kidney cancer	0.000241	0.000676	CcSEcCtD
Glipizide—Dyspepsia—Capecitabine—kidney cancer	0.000238	0.000668	CcSEcCtD
Glipizide—Visual impairment—Doxorubicin—kidney cancer	0.000236	0.000663	CcSEcCtD
Glipizide—Asthenia—Paclitaxel—kidney cancer	0.000236	0.000663	CcSEcCtD
Glipizide—Decreased appetite—Capecitabine—kidney cancer	0.000235	0.000659	CcSEcCtD
Glipizide—Nausea—Gemcitabine—kidney cancer	0.000234	0.000656	CcSEcCtD
Glipizide—Gastrointestinal disorder—Capecitabine—kidney cancer	0.000233	0.000655	CcSEcCtD
Glipizide—Pruritus—Paclitaxel—kidney cancer	0.000233	0.000654	CcSEcCtD
Glipizide—Pain—Capecitabine—kidney cancer	0.000231	0.000649	CcSEcCtD
Glipizide—Constipation—Capecitabine—kidney cancer	0.000231	0.000649	CcSEcCtD
Glipizide—Eye disorder—Doxorubicin—kidney cancer	0.000229	0.000643	CcSEcCtD
Glipizide—Flushing—Doxorubicin—kidney cancer	0.000227	0.000639	CcSEcCtD
Glipizide—Diarrhoea—Paclitaxel—kidney cancer	0.000225	0.000632	CcSEcCtD
Glipizide—Feeling abnormal—Capecitabine—kidney cancer	0.000223	0.000625	CcSEcCtD
Glipizide—Gastrointestinal pain—Capecitabine—kidney cancer	0.000221	0.00062	CcSEcCtD
Glipizide—Chills—Doxorubicin—kidney cancer	0.00022	0.000617	CcSEcCtD
Glipizide—Arrhythmia—Doxorubicin—kidney cancer	0.000219	0.000615	CcSEcCtD
Glipizide—Dizziness—Paclitaxel—kidney cancer	0.000218	0.000611	CcSEcCtD
Glipizide—Urticaria—Capecitabine—kidney cancer	0.000215	0.000603	CcSEcCtD
Glipizide—Abdominal pain—Capecitabine—kidney cancer	0.000214	0.0006	CcSEcCtD
Glipizide—Erythema—Doxorubicin—kidney cancer	0.000213	0.000599	CcSEcCtD
Glipizide—Flatulence—Doxorubicin—kidney cancer	0.00021	0.00059	CcSEcCtD
Glipizide—Tension—Doxorubicin—kidney cancer	0.000209	0.000588	CcSEcCtD
Glipizide—Vomiting—Paclitaxel—kidney cancer	0.000209	0.000588	CcSEcCtD
Glipizide—Rash—Paclitaxel—kidney cancer	0.000208	0.000583	CcSEcCtD
Glipizide—Dermatitis—Paclitaxel—kidney cancer	0.000207	0.000582	CcSEcCtD
Glipizide—Nervousness—Doxorubicin—kidney cancer	0.000207	0.000582	CcSEcCtD
Glipizide—Headache—Paclitaxel—kidney cancer	0.000206	0.000579	CcSEcCtD
Glipizide—Muscle spasms—Doxorubicin—kidney cancer	0.000205	0.000576	CcSEcCtD
Glipizide—Vision blurred—Doxorubicin—kidney cancer	0.000201	0.000565	CcSEcCtD
Glipizide—Hypersensitivity—Capecitabine—kidney cancer	0.000199	0.000559	CcSEcCtD
Glipizide—Ill-defined disorder—Doxorubicin—kidney cancer	0.000198	0.000556	CcSEcCtD
Glipizide—Nausea—Paclitaxel—kidney cancer	0.000196	0.000549	CcSEcCtD
Glipizide—Asthenia—Capecitabine—kidney cancer	0.000194	0.000544	CcSEcCtD
Glipizide—Malaise—Doxorubicin—kidney cancer	0.000192	0.00054	CcSEcCtD
Glipizide—Vertigo—Doxorubicin—kidney cancer	0.000192	0.000538	CcSEcCtD
Glipizide—Syncope—Doxorubicin—kidney cancer	0.000191	0.000537	CcSEcCtD
Glipizide—Pruritus—Capecitabine—kidney cancer	0.000191	0.000537	CcSEcCtD
Glipizide—Leukopenia—Doxorubicin—kidney cancer	0.000191	0.000536	CcSEcCtD
Glipizide—Loss of consciousness—Doxorubicin—kidney cancer	0.000188	0.000527	CcSEcCtD
Glipizide—Diarrhoea—Capecitabine—kidney cancer	0.000185	0.000519	CcSEcCtD
Glipizide—Hypertension—Doxorubicin—kidney cancer	0.000184	0.000517	CcSEcCtD
Glipizide—Arthralgia—Doxorubicin—kidney cancer	0.000182	0.00051	CcSEcCtD
Glipizide—Myalgia—Doxorubicin—kidney cancer	0.000182	0.00051	CcSEcCtD
Glipizide—Anxiety—Doxorubicin—kidney cancer	0.000181	0.000508	CcSEcCtD
Glipizide—Discomfort—Doxorubicin—kidney cancer	0.000179	0.000504	CcSEcCtD
Glipizide—Dizziness—Capecitabine—kidney cancer	0.000179	0.000502	CcSEcCtD
Glipizide—Confusional state—Doxorubicin—kidney cancer	0.000176	0.000493	CcSEcCtD
Glipizide—Oedema—Doxorubicin—kidney cancer	0.000174	0.000489	CcSEcCtD
Glipizide—Vomiting—Capecitabine—kidney cancer	0.000172	0.000482	CcSEcCtD
Glipizide—Shock—Doxorubicin—kidney cancer	0.000171	0.000481	CcSEcCtD
Glipizide—Thrombocytopenia—Doxorubicin—kidney cancer	0.000171	0.000479	CcSEcCtD
Glipizide—Rash—Capecitabine—kidney cancer	0.00017	0.000478	CcSEcCtD
Glipizide—Dermatitis—Capecitabine—kidney cancer	0.00017	0.000478	CcSEcCtD
Glipizide—Headache—Capecitabine—kidney cancer	0.000169	0.000475	CcSEcCtD
Glipizide—Hyperhidrosis—Doxorubicin—kidney cancer	0.000168	0.000473	CcSEcCtD
Glipizide—Anorexia—Doxorubicin—kidney cancer	0.000166	0.000466	CcSEcCtD
Glipizide—Nausea—Capecitabine—kidney cancer	0.00016	0.000451	CcSEcCtD
Glipizide—Musculoskeletal discomfort—Doxorubicin—kidney cancer	0.000159	0.000445	CcSEcCtD
Glipizide—Insomnia—Doxorubicin—kidney cancer	0.000158	0.000442	CcSEcCtD
Glipizide—Paraesthesia—Doxorubicin—kidney cancer	0.000156	0.000439	CcSEcCtD
Glipizide—Dyspnoea—Doxorubicin—kidney cancer	0.000155	0.000436	CcSEcCtD
Glipizide—Somnolence—Doxorubicin—kidney cancer	0.000155	0.000435	CcSEcCtD
Glipizide—KCNJ11—Metabolism—APRT—kidney cancer	0.000155	0.00194	CbGpPWpGaD
Glipizide—Dyspepsia—Doxorubicin—kidney cancer	0.000153	0.00043	CcSEcCtD
Glipizide—PPARG—SREBP signalling—PIK3CA—kidney cancer	0.000153	0.00192	CbGpPWpGaD
Glipizide—Decreased appetite—Doxorubicin—kidney cancer	0.000151	0.000425	CcSEcCtD
Glipizide—PPARG—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	0.000151	0.00189	CbGpPWpGaD
Glipizide—PPARG—Metabolism—PDHB—kidney cancer	0.000151	0.00189	CbGpPWpGaD
Glipizide—Gastrointestinal disorder—Doxorubicin—kidney cancer	0.00015	0.000422	CcSEcCtD
Glipizide—ABCC8—Metabolism—GPC3—kidney cancer	0.00015	0.00188	CbGpPWpGaD
Glipizide—Constipation—Doxorubicin—kidney cancer	0.000149	0.000418	CcSEcCtD
Glipizide—Pain—Doxorubicin—kidney cancer	0.000149	0.000418	CcSEcCtD
Glipizide—ABCC8—Transmembrane transport of small molecules—SLC5A5—kidney cancer	0.000146	0.00183	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—CA2—kidney cancer	0.000146	0.00183	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—GPC3—kidney cancer	0.000145	0.00182	CbGpPWpGaD
Glipizide—Feeling abnormal—Doxorubicin—kidney cancer	0.000144	0.000403	CcSEcCtD
Glipizide—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—kidney cancer	0.000143	0.00179	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—CTNNA1—kidney cancer	0.000143	0.00179	CbGpPWpGaD
Glipizide—Gastrointestinal pain—Doxorubicin—kidney cancer	0.000142	0.0004	CcSEcCtD
Glipizide—ABCC8—Metabolism—ALAD—kidney cancer	0.000142	0.00178	CbGpPWpGaD
Glipizide—PPARG—Metabolism—CCBL1—kidney cancer	0.000142	0.00178	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—CA2—kidney cancer	0.000141	0.00177	CbGpPWpGaD
Glipizide—ABCC8—Transmembrane transport of small molecules—SLC2A1—kidney cancer	0.000141	0.00177	CbGpPWpGaD
Glipizide—ABCC8—Neuronal System—BRAF—kidney cancer	0.000141	0.00176	CbGpPWpGaD
Glipizide—CYP3A4—Tryptophan metabolism—CYP1A1—kidney cancer	0.000141	0.00176	CbGpPWpGaD
Glipizide—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	0.00014	0.00175	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—ST3GAL2—kidney cancer	0.000139	0.00174	CbGpPWpGaD
Glipizide—Urticaria—Doxorubicin—kidney cancer	0.000138	0.000388	CcSEcCtD
Glipizide—CYP3A4—Biological oxidations—ALDH1A1—kidney cancer	0.000138	0.00173	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—ALAD—kidney cancer	0.000138	0.00173	CbGpPWpGaD
Glipizide—Abdominal pain—Doxorubicin—kidney cancer	0.000138	0.000386	CcSEcCtD
Glipizide—PPARG—Developmental Biology—PAX6—kidney cancer	0.000137	0.00171	CbGpPWpGaD
Glipizide—KCNJ11—Neuronal System—BRAF—kidney cancer	0.000136	0.00171	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—ALDH1A1—kidney cancer	0.000136	0.0017	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—ST3GAL2—kidney cancer	0.000134	0.00168	CbGpPWpGaD
Glipizide—PPARG—Adipogenesis—CTNNB1—kidney cancer	0.000134	0.00168	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—ALDH1A1—kidney cancer	0.000131	0.00165	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—SLC5A3—kidney cancer	0.00013	0.00163	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—PGK1—kidney cancer	0.00013	0.00163	CbGpPWpGaD
Glipizide—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	0.000129	0.00161	CbGpPWpGaD
Glipizide—Hypersensitivity—Doxorubicin—kidney cancer	0.000128	0.00036	CcSEcCtD
Glipizide—PPARG—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	0.000128	0.00161	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—LDHB—kidney cancer	0.000127	0.0016	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—SLC5A3—kidney cancer	0.000126	0.00158	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—PGK1—kidney cancer	0.000126	0.00158	CbGpPWpGaD
Glipizide—PPARG—Generic Transcription Pathway—JUNB—kidney cancer	0.000126	0.00158	CbGpPWpGaD
Glipizide—Asthenia—Doxorubicin—kidney cancer	0.000125	0.000351	CcSEcCtD
Glipizide—PPARG—Gene Expression—EEF2—kidney cancer	0.000125	0.00157	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—LDHB—kidney cancer	0.000124	0.00155	CbGpPWpGaD
Glipizide—Pruritus—Doxorubicin—kidney cancer	0.000123	0.000346	CcSEcCtD
Glipizide—CYP2C9—Biological oxidations—GSTT1—kidney cancer	0.000123	0.00154	CbGpPWpGaD
Glipizide—PPARG—Metabolism—GLIPR1—kidney cancer	0.000123	0.00154	CbGpPWpGaD
Glipizide—PPARG—Metabolism—PPAT—kidney cancer	0.000123	0.00154	CbGpPWpGaD
Glipizide—PPARG—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	0.000121	0.00152	CbGpPWpGaD
Glipizide—PPARG—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	0.00012	0.0015	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—TET2—kidney cancer	0.00012	0.0015	CbGpPWpGaD
Glipizide—Diarrhoea—Doxorubicin—kidney cancer	0.000119	0.000335	CcSEcCtD
Glipizide—CYP2C9—Arachidonic acid metabolism—PTGS2—kidney cancer	0.000119	0.00149	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—PAK1—kidney cancer	0.000118	0.00148	CbGpPWpGaD
Glipizide—ABCC8—Neuronal System—RAF1—kidney cancer	0.000117	0.00147	CbGpPWpGaD
Glipizide—CYP2C9—Biological oxidations—PTGS1—kidney cancer	0.000115	0.00144	CbGpPWpGaD
Glipizide—Dizziness—Doxorubicin—kidney cancer	0.000115	0.000323	CcSEcCtD
Glipizide—PPARG—Metabolism—FH—kidney cancer	0.000114	0.00143	CbGpPWpGaD
Glipizide—PPARG—Metabolism—APRT—kidney cancer	0.000114	0.00143	CbGpPWpGaD
Glipizide—KCNJ11—Neuronal System—RAF1—kidney cancer	0.000114	0.00143	CbGpPWpGaD
Glipizide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—kidney cancer	0.000114	0.00142	CbGpPWpGaD
Glipizide—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—kidney cancer	0.000112	0.00141	CbGpPWpGaD
Glipizide—PPARG—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	0.000112	0.0014	CbGpPWpGaD
Glipizide—ABCC8—Transmembrane transport of small molecules—ABCB1—kidney cancer	0.000112	0.0014	CbGpPWpGaD
Glipizide—Vomiting—Doxorubicin—kidney cancer	0.000111	0.000311	CcSEcCtD
Glipizide—ABCC8—Metabolism—CA9—kidney cancer	0.00011	0.00138	CbGpPWpGaD
Glipizide—Rash—Doxorubicin—kidney cancer	0.00011	0.000308	CcSEcCtD
Glipizide—Dermatitis—Doxorubicin—kidney cancer	0.00011	0.000308	CcSEcCtD
Glipizide—PPARG—Gene Expression—TCEB2—kidney cancer	0.00011	0.00137	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—TCEB1—kidney cancer	0.00011	0.00137	CbGpPWpGaD
Glipizide—Headache—Doxorubicin—kidney cancer	0.000109	0.000306	CcSEcCtD
Glipizide—PPARG—Metabolism—GPC3—kidney cancer	0.000107	0.00135	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—CA9—kidney cancer	0.000107	0.00134	CbGpPWpGaD
Glipizide—PPARG—Metabolism—CA2—kidney cancer	0.000104	0.00131	CbGpPWpGaD
Glipizide—CYP2C9—Phase 1 - Functionalization of compounds—POMC—kidney cancer	0.000104	0.00131	CbGpPWpGaD
Glipizide—Nausea—Doxorubicin—kidney cancer	0.000103	0.00029	CcSEcCtD
Glipizide—PPARG—Generic Transcription Pathway—CDKN2B—kidney cancer	0.000102	0.00128	CbGpPWpGaD
Glipizide—PPARG—Metabolism—ALAD—kidney cancer	0.000102	0.00128	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—GLIPR1—kidney cancer	0.000102	0.00127	CbGpPWpGaD
Glipizide—PPARG—Metabolism—ST3GAL2—kidney cancer	9.94e-05	0.00125	CbGpPWpGaD
Glipizide—PPARG—Metabolism—ALDH1A1—kidney cancer	9.71e-05	0.00122	CbGpPWpGaD
Glipizide—PPARG—Circadian rythm related genes—JUN—kidney cancer	9.54e-05	0.0012	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—CRABP1—kidney cancer	9.39e-05	0.00118	CbGpPWpGaD
Glipizide—PPARG—Metabolism—PGK1—kidney cancer	9.31e-05	0.00117	CbGpPWpGaD
Glipizide—PPARG—Metabolism—SLC5A3—kidney cancer	9.31e-05	0.00117	CbGpPWpGaD
Glipizide—PPARG—Circadian rythm related genes—PTEN—kidney cancer	9.23e-05	0.00116	CbGpPWpGaD
Glipizide—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	9.21e-05	0.00115	CbGpPWpGaD
Glipizide—PPARG—Metabolism—LDHB—kidney cancer	9.13e-05	0.00114	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—CRABP1—kidney cancer	9.11e-05	0.00114	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—RPL14—kidney cancer	8.9e-05	0.00112	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—ITPR2—kidney cancer	8.73e-05	0.00109	CbGpPWpGaD
Glipizide—CYP2C9—Biological oxidations—GSTP1—kidney cancer	8.52e-05	0.00107	CbGpPWpGaD
Glipizide—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	8.47e-05	0.00106	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—ITPR2—kidney cancer	8.47e-05	0.00106	CbGpPWpGaD
Glipizide—CYP2C9—Metapathway biotransformation—GSTP1—kidney cancer	8.4e-05	0.00105	CbGpPWpGaD
Glipizide—CYP3A4—Biological oxidations—GSTT1—kidney cancer	8.11e-05	0.00102	CbGpPWpGaD
Glipizide—ABCC8—Neuronal System—MAPK1—kidney cancer	8.05e-05	0.00101	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—ACHE—kidney cancer	7.96e-05	0.000998	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—GSTT1—kidney cancer	7.96e-05	0.000998	CbGpPWpGaD
Glipizide—PPARG—Metabolism—CA9—kidney cancer	7.92e-05	0.000992	CbGpPWpGaD
Glipizide—CYP2C9—Biological oxidations—GSTM1—kidney cancer	7.83e-05	0.000981	CbGpPWpGaD
Glipizide—KCNJ11—Neuronal System—MAPK1—kidney cancer	7.81e-05	0.000978	CbGpPWpGaD
Glipizide—PPARG—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	7.74e-05	0.00097	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—GSTT1—kidney cancer	7.72e-05	0.000968	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—ACHE—kidney cancer	7.72e-05	0.000968	CbGpPWpGaD
Glipizide—CYP2C9—Metapathway biotransformation—GSTM1—kidney cancer	7.72e-05	0.000967	CbGpPWpGaD
Glipizide—CYP3A4—Biological oxidations—PTGS1—kidney cancer	7.6e-05	0.000952	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—SCARB1—kidney cancer	7.54e-05	0.000945	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—PTGS1—kidney cancer	7.46e-05	0.000935	CbGpPWpGaD
Glipizide—CYP2C9—Biological oxidations—CYP1A1—kidney cancer	7.42e-05	0.00093	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—KDR—kidney cancer	7.37e-05	0.000923	CbGpPWpGaD
Glipizide—CYP2C9—Metapathway biotransformation—CYP1A1—kidney cancer	7.32e-05	0.000917	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—PSMD7—kidney cancer	7.32e-05	0.000917	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—SCARB1—kidney cancer	7.31e-05	0.000916	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—EIF4EBP1—kidney cancer	7.26e-05	0.000909	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—HSPB1—kidney cancer	7.26e-05	0.000909	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—PTGS1—kidney cancer	7.24e-05	0.000907	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—MET—kidney cancer	7.21e-05	0.000903	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—PSMD7—kidney cancer	7.1e-05	0.000889	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—BCHE—kidney cancer	6.94e-05	0.000869	CbGpPWpGaD
Glipizide—CYP3A4—Phase 1 - Functionalization of compounds—POMC—kidney cancer	6.87e-05	0.000861	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—SLC5A5—kidney cancer	6.85e-05	0.000859	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—PSMD7—kidney cancer	6.75e-05	0.000845	CbGpPWpGaD
Glipizide—PPARG—Metabolism—CRABP1—kidney cancer	6.73e-05	0.000844	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—BCHE—kidney cancer	6.73e-05	0.000843	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—SLC5A5—kidney cancer	6.65e-05	0.000833	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—SLC2A1—kidney cancer	6.62e-05	0.000829	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—ACY1—kidney cancer	6.53e-05	0.000818	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—SLC2A1—kidney cancer	6.42e-05	0.000804	CbGpPWpGaD
Glipizide—ABCC8—Transmembrane transport of small molecules—RAF1—kidney cancer	6.31e-05	0.000791	CbGpPWpGaD
Glipizide—PPARG—Circadian rythm related genes—TP53—kidney cancer	6.3e-05	0.000789	CbGpPWpGaD
Glipizide—PPARG—Metabolism—ITPR2—kidney cancer	6.26e-05	0.000784	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—JUNB—kidney cancer	6.06e-05	0.000759	CbGpPWpGaD
Glipizide—PPARG—Metabolism of lipids and lipoproteins—POMC—kidney cancer	5.77e-05	0.000723	CbGpPWpGaD
Glipizide—PPARG—Metabolism—GSTT1—kidney cancer	5.71e-05	0.000715	CbGpPWpGaD
Glipizide—PPARG—Metabolism—ACHE—kidney cancer	5.71e-05	0.000715	CbGpPWpGaD
Glipizide—CYP3A4—Biological oxidations—GSTP1—kidney cancer	5.62e-05	0.000704	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	5.57e-05	0.000698	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—PDHB—kidney cancer	5.55e-05	0.000696	CbGpPWpGaD
Glipizide—CYP3A4—Metapathway biotransformation—GSTP1—kidney cancer	5.54e-05	0.000694	CbGpPWpGaD
Glipizide—CYP2C9—Biological oxidations—POMC—kidney cancer	5.53e-05	0.000693	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—GSTP1—kidney cancer	5.52e-05	0.000692	CbGpPWpGaD
Glipizide—PPARG—Metabolism—SCARB1—kidney cancer	5.4e-05	0.000677	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—GSTP1—kidney cancer	5.35e-05	0.000671	CbGpPWpGaD
Glipizide—PPARG—Metabolism—PTGS1—kidney cancer	5.35e-05	0.00067	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—RAF1—kidney cancer	5.33e-05	0.000667	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—RELA—kidney cancer	5.3e-05	0.000665	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—ERBB2—kidney cancer	5.27e-05	0.00066	CbGpPWpGaD
Glipizide—PPARG—Metabolism—PSMD7—kidney cancer	5.25e-05	0.000657	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—ABCB1—kidney cancer	5.23e-05	0.000655	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—CCBL1—kidney cancer	5.22e-05	0.000654	CbGpPWpGaD
Glipizide—CYP3A4—Biological oxidations—GSTM1—kidney cancer	5.16e-05	0.000647	CbGpPWpGaD
Glipizide—CYP3A4—Metapathway biotransformation—GSTM1—kidney cancer	5.09e-05	0.000638	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—GSTM1—kidney cancer	5.07e-05	0.000636	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—ABCB1—kidney cancer	5.07e-05	0.000635	CbGpPWpGaD
Glipizide—PPARG—Metabolism—BCHE—kidney cancer	4.97e-05	0.000623	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—CDKN2B—kidney cancer	4.93e-05	0.000618	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—GSTM1—kidney cancer	4.92e-05	0.000616	CbGpPWpGaD
Glipizide—PPARG—Metabolism—SLC5A5—kidney cancer	4.91e-05	0.000615	CbGpPWpGaD
Glipizide—CYP3A4—Biological oxidations—CYP1A1—kidney cancer	4.89e-05	0.000613	CbGpPWpGaD
Glipizide—CYP3A4—Metapathway biotransformation—CYP1A1—kidney cancer	4.83e-05	0.000605	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—CYP1A1—kidney cancer	4.81e-05	0.000603	CbGpPWpGaD
Glipizide—PPARG—Metabolism—SLC2A1—kidney cancer	4.74e-05	0.000594	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	4.72e-05	0.000591	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—CYP1A1—kidney cancer	4.66e-05	0.000584	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—CTNNB1—kidney cancer	4.61e-05	0.000578	CbGpPWpGaD
Glipizide—PPARG—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	4.6e-05	0.000577	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—PPAT—kidney cancer	4.53e-05	0.000567	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—GLIPR1—kidney cancer	4.53e-05	0.000567	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	4.47e-05	0.00056	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	4.42e-05	0.000554	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—ACY1—kidney cancer	4.31e-05	0.000539	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—FH—kidney cancer	4.21e-05	0.000527	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—APRT—kidney cancer	4.21e-05	0.000527	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	4.11e-05	0.000515	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—VEGFA—kidney cancer	4.06e-05	0.000509	CbGpPWpGaD
Glipizide—PPARG—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	4.01e-05	0.000503	CbGpPWpGaD
Glipizide—PPARG—Generic Transcription Pathway—MYC—kidney cancer	3.97e-05	0.000497	CbGpPWpGaD
Glipizide—PPARG—Metabolism—GSTP1—kidney cancer	3.96e-05	0.000496	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—GPC3—kidney cancer	3.96e-05	0.000496	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—CA2—kidney cancer	3.85e-05	0.000482	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—MAPK3—kidney cancer	3.84e-05	0.000481	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—ALAD—kidney cancer	3.75e-05	0.00047	CbGpPWpGaD
Glipizide—PPARG—Metabolism—ABCB1—kidney cancer	3.75e-05	0.000469	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PDHB—kidney cancer	3.66e-05	0.000459	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—ST3GAL2—kidney cancer	3.66e-05	0.000459	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—MAPK1—kidney cancer	3.65e-05	0.000458	CbGpPWpGaD
Glipizide—CYP3A4—Biological oxidations—POMC—kidney cancer	3.65e-05	0.000457	CbGpPWpGaD
Glipizide—PPARG—Metabolism—GSTM1—kidney cancer	3.64e-05	0.000456	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—POMC—kidney cancer	3.59e-05	0.000449	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—ALDH1A1—kidney cancer	3.58e-05	0.000448	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—POMC—kidney cancer	3.48e-05	0.000436	CbGpPWpGaD
Glipizide—PPARG—Developmental Biology—KRAS—kidney cancer	3.45e-05	0.000432	CbGpPWpGaD
Glipizide—PPARG—Metabolism—CYP1A1—kidney cancer	3.45e-05	0.000432	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—CCBL1—kidney cancer	3.44e-05	0.000431	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—PGK1—kidney cancer	3.43e-05	0.00043	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—SLC5A3—kidney cancer	3.43e-05	0.00043	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—LDHB—kidney cancer	3.36e-05	0.000421	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PPAT—kidney cancer	2.98e-05	0.000374	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—GLIPR1—kidney cancer	2.98e-05	0.000374	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—CA9—kidney cancer	2.92e-05	0.000365	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—PTGS2—kidney cancer	2.86e-05	0.000358	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	2.85e-05	0.000357	CbGpPWpGaD
Glipizide—PPARG—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	2.83e-05	0.000355	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—FH—kidney cancer	2.77e-05	0.000348	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—APRT—kidney cancer	2.77e-05	0.000348	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—PTGS2—kidney cancer	2.77e-05	0.000347	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—GPC3—kidney cancer	2.61e-05	0.000327	CbGpPWpGaD
Glipizide—PPARG—Metabolism—POMC—kidney cancer	2.57e-05	0.000322	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—CA2—kidney cancer	2.54e-05	0.000318	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—PTEN—kidney cancer	2.49e-05	0.000313	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—CRABP1—kidney cancer	2.48e-05	0.000311	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—ALAD—kidney cancer	2.47e-05	0.00031	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—PTEN—kidney cancer	2.42e-05	0.000303	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—ST3GAL2—kidney cancer	2.41e-05	0.000302	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—ALDH1A1—kidney cancer	2.36e-05	0.000296	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—ITPR2—kidney cancer	2.31e-05	0.000289	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PGK1—kidney cancer	2.26e-05	0.000283	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—SLC5A3—kidney cancer	2.26e-05	0.000283	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—LDHB—kidney cancer	2.22e-05	0.000278	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—POMC—kidney cancer	2.12e-05	0.000266	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—GSTT1—kidney cancer	2.1e-05	0.000263	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—ACHE—kidney cancer	2.1e-05	0.000263	CbGpPWpGaD
Glipizide—PPARG—Metabolism—PTGS2—kidney cancer	2.05e-05	0.000257	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—SCARB1—kidney cancer	1.99e-05	0.000249	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—PTGS1—kidney cancer	1.97e-05	0.000247	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—MAPK3—kidney cancer	1.96e-05	0.000246	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—PSMD7—kidney cancer	1.93e-05	0.000242	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—CA9—kidney cancer	1.92e-05	0.000241	CbGpPWpGaD
Glipizide—PPARG—Gene Expression—MYC—kidney cancer	1.91e-05	0.000239	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—BCHE—kidney cancer	1.83e-05	0.000229	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—SLC5A5—kidney cancer	1.81e-05	0.000227	CbGpPWpGaD
Glipizide—PPARG—Metabolism—PTEN—kidney cancer	1.79e-05	0.000224	CbGpPWpGaD
Glipizide—ABCC8—Metabolism—PIK3CA—kidney cancer	1.76e-05	0.00022	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—SLC2A1—kidney cancer	1.75e-05	0.000219	CbGpPWpGaD
Glipizide—KCNJ11—Metabolism—PIK3CA—kidney cancer	1.71e-05	0.000214	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	1.69e-05	0.000212	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—CRABP1—kidney cancer	1.64e-05	0.000205	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—ITPR2—kidney cancer	1.52e-05	0.00019	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	1.48e-05	0.000185	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—GSTP1—kidney cancer	1.46e-05	0.000183	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—ACHE—kidney cancer	1.39e-05	0.000174	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—GSTT1—kidney cancer	1.39e-05	0.000174	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—ABCB1—kidney cancer	1.38e-05	0.000173	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—GSTM1—kidney cancer	1.34e-05	0.000168	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—SCARB1—kidney cancer	1.31e-05	0.000164	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PTGS1—kidney cancer	1.3e-05	0.000163	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PSMD7—kidney cancer	1.27e-05	0.00016	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—CYP1A1—kidney cancer	1.27e-05	0.000159	CbGpPWpGaD
Glipizide—PPARG—Metabolism—PIK3CA—kidney cancer	1.26e-05	0.000158	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—BCHE—kidney cancer	1.21e-05	0.000151	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—SLC5A5—kidney cancer	1.19e-05	0.000149	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—SLC2A1—kidney cancer	1.15e-05	0.000144	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.04e-05	0.000131	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—GSTP1—kidney cancer	9.61e-06	0.00012	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—POMC—kidney cancer	9.46e-06	0.000119	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—ABCB1—kidney cancer	9.1e-06	0.000114	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—GSTM1—kidney cancer	8.83e-06	0.000111	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—CYP1A1—kidney cancer	8.37e-06	0.000105	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—PTGS2—kidney cancer	7.55e-06	9.46e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—PTEN—kidney cancer	6.58e-06	8.25e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—POMC—kidney cancer	6.24e-06	7.82e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PTGS2—kidney cancer	4.98e-06	6.24e-05	CbGpPWpGaD
Glipizide—CYP2C9—Metabolism—PIK3CA—kidney cancer	4.64e-06	5.82e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PTEN—kidney cancer	4.34e-06	5.44e-05	CbGpPWpGaD
Glipizide—CYP3A4—Metabolism—PIK3CA—kidney cancer	3.06e-06	3.84e-05	CbGpPWpGaD
